Proximagen Group plc - Product Pipeline Review - 2012 New Report


Naperville, IL -- (SBWIRE) -- 09/27/2012 -- Proximagen Group plc - Product Pipeline Review - 2012 provides data on the Proximagen Group plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- Proximagen Group plc - Brief Proximagen Group plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Proximagen Group plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Proximagen Group plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Proximagen Group plc’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Proximagen Group plc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Proximagen Group plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Proximagen Group plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Proximagen Group plc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Proximagen Group plc and identify potential opportunities in those areas.


Current R&D Portfolio of Proximagen Group plc; Proximagen Group plc - Key Therapeutics; Proximagen Group plc - Pipeline Overview and Promising Molecules; Proximagen Group plc - News; Proximagen Group plc - Latest Updates; Proximagen Group plc - Pipeline; Proximagen Group plc - Discontinued/Dormant Projects

To view table of contents for this market report please visit: